Cancer, Epigenetics And The Nobel Prizes

The Nobel Prize in Physiology or Medicine 2012 have been awarded jointly to Sir John B. Gurdon and Shinya Yamanaka “for the discovery that mature cells can be reprogrammed to become pluripotent” as it is described in the Nobel Prize web site. Professors Gurdon and Yamanaka have all the merits to be...

Full description

Bibliographic Details
Author: Esteller, Manel
Format: Article
Status:Published version
Publication date:2012
Country:España
Institution:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repository:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/123975
Online Access:https://hdl.handle.net/2445/123975
Access Level:Open access
Keyword:Premis Nobel
Càncer
Epigenètica
Nobel Prizes
Cancer
Epigenetics
_version_ 1878729770046324736
author Esteller, Manel
author_browse Esteller, Manel
author_facet Esteller, Manel
author_role author
collection Recercat. Dipósit de la Recerca de Catalunya
description The Nobel Prize in Physiology or Medicine 2012 have been awarded jointly to Sir John B. Gurdon and Shinya Yamanaka “for the discovery that mature cells can be reprogrammed to become pluripotent” as it is described in the Nobel Prize web site. Professors Gurdon and Yamanaka have all the merits to be bestowed with such a prestigious award for their seminal discoveries in the area. However, we can also consider this annual prize as a recognition to Epigenetics, similarly to the Nobel Prize of 2006 for Andrew Z. Fire and Craig C. Mello for their of RNA interference - gene silencing by doublestranded RNA. Reprogramming requires changing the epigenome of the cells and non-coding RNAs are critical elements in the establishment of epigenetic patterns
eu_rights_str_mv openAccess
format article
id ES_0ea41aaa44c87f5f3ce502aafc8f0795
institution Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
network_acronym_str ES
network_name_str España
oai_identifier_str oai:recercat.cat:2445/123975
publishDate 2012
publishDateSort 2012
publisher Elsevier Sci Ltd
publisherStr Elsevier Sci Ltd
reponame_str Recercat. Dipósit de la Recerca de Catalunya
spelling Cancer, Epigenetics And The Nobel Prizes Esteller, Manel Premis Nobel Càncer Epigenètica Nobel Prizes Cancer Epigenetics The Nobel Prize in Physiology or Medicine 2012 have been awarded jointly to Sir John B. Gurdon and Shinya Yamanaka “for the discovery that mature cells can be reprogrammed to become pluripotent” as it is described in the Nobel Prize web site. Professors Gurdon and Yamanaka have all the merits to be bestowed with such a prestigious award for their seminal discoveries in the area. However, we can also consider this annual prize as a recognition to Epigenetics, similarly to the Nobel Prize of 2006 for Andrew Z. Fire and Craig C. Mello for their of RNA interference - gene silencing by doublestranded RNA. Reprogramming requires changing the epigenome of the cells and non-coding RNAs are critical elements in the establishment of epigenetic patterns Elsevier Sci Ltd https://hdl.handle.net/2445/123975
spellingShingle Cancer, Epigenetics And The Nobel Prizes
Esteller, Manel
Premis Nobel
Càncer
Epigenètica
Nobel Prizes
Cancer
Epigenetics
status_str publishedVersion
title Cancer, Epigenetics And The Nobel Prizes
title_full Cancer, Epigenetics And The Nobel Prizes
title_fullStr Cancer, Epigenetics And The Nobel Prizes
title_full_unstemmed Cancer, Epigenetics And The Nobel Prizes
title_short Cancer, Epigenetics And The Nobel Prizes
title_sort Cancer, Epigenetics And The Nobel Prizes
topic Premis Nobel
Càncer
Epigenètica
Nobel Prizes
Cancer
Epigenetics
topic_facet Premis Nobel
Càncer
Epigenètica
Nobel Prizes
Cancer
Epigenetics
url https://hdl.handle.net/2445/123975